Caption Management, LLC Exelixis, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $2.89 Million - $3.63 Million	-131,500 Reduced 65.52%	69,200 $1.8 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $3.37 Million - $3.93 Million	165,700 Added 473.43%	200,700 $4.51 Million
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $1.6 Million - $1.9 Million	-79,300 Reduced 69.38%	35,000 $830,000
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $1.18 Million - $1.47 Million	-61,100 Reduced 34.83%	114,300 $2.74 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $2.77 Million - $3.31 Million	145,400 Added 484.67%	175,400 $3.83 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $2.18 Million - $2.46 Million	-120,000 Reduced 80.0%	30,000 $573,000
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $700,900 - $834,630	43,000 Added 40.19%	150,000 $2.91 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $29,920 - $34,780	2,000 Added 1.9%	107,000 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $235,200 - $334,050	15,000 Added 16.67%	105,000 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $1.05 Million - $1.39 Million	60,000 Added 200.0%	90,000 $1.87 Million
Q1 2022 May 13, 2022	SELL	$17.03 - $22.67 $596,050 - $793,450	-35,000 Reduced 53.85%	30,000 $680,000
Q4 2021 Feb 11, 2022	BUY	$15.84 - $21.88 $79,200 - $109,400	5,000 Added 8.33%	65,000 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $1.08 Million - $1.53 Million	60,000 New	60,000 $1.09 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $1.23 Million - $1.51 Million	-60,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $229,875 - $310,000	-12,500 Reduced 17.24%	60,000 $1.2 Million
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $1.5 Million - $1.95 Million	72,500 New	72,500 $1.77 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $329,200 - $548,400	-20,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $289,200 - $436,000	-20,000 Reduced 50.0%	20,000 $344,000
Q4 2019 Feb 13, 2020	SELL	$15.15 - $18.89 $757,500 - $944,500	-50,000 Reduced 55.56%	40,000 $705,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $1.06 Million - $1.36 Million	-60,000 Reduced 40.0%	90,000 $1.59 Million
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $2.93 Million - $3.7 Million	-149,600 Reduced 49.93%	150,000 $3.57 Million
Q4 2018 Jan 30, 2019	BUY	$13.65 - $21.8 $4.09 Million - $6.53 Million	299,600 New	299,600 $5.89 Million

Others Institutions Holding EXEL

# of Institutions

495

Shares Held

244M

Call Options Held

2.4M

Put Options Held

2.21M

Black Rock Inc. New York, NY

33.5M
Shares

$1.17 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.03 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$891 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$538 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$401 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account